Table 6 Binding affinity and interaction profile of test compounds with CDK2.

From: Integrated DFT, molecular docking, and molecular dynamics investigation of some novel 2-thiohydantoin analogues as potent CDK2 inhibitors for anticancer therapy

Compound

Binding Affinity (kcal/mol)

H-Bond Interactions

Hydrophobic Interactions

Number of H-bonds

1

−7.792

None

Ile10, Val18, Ala31, Lys33, Val64, Phe80, Leu134

0

2a

−8.595

Lys33

Ile10, Val18, Ala31, Val64, Phe80, Leu134, Ala144

1

2b

−9.269

Lys33, Thr14

Ile10, Val18, Ala31, Val64, Phe80, Lys129, Leu134, Ala144

2

2c

−9.312

Lys33, Thr14

Ile10, Val18, Ala31, Val64, Phe80, Leu134, Ala144

2

2d

−9.303

Lys33, Thr14

Ile10, Val18, Ala31, Val64, Phe80, Lys129, Leu134, Ala144

2

2e

−9.090

Lys33, Val164ᵃ

Ile10, Val18, Ala31, Val64, Phe80, Lys129, Leu134, Ala144

2

2f

−8.175

Lys33, Thr14, Gly13ᵃ, Leu83ᵃ

Ile10, Val18, Ala31, Val64, Phe80, Leu134, Ala144

4

2g

−8.462

Lys33, Tyr15, Leu83ᵃ, Asn132ᵃ

Ile10, Val18, Ala31, Val64, Phe80, Leu134

4

2h

−7.949

Glu81ᵃ, His84ᵃ

Ile10, Val18, Ala31, Lys33, Val64, Phe80, Leu134

2

2i

−8.105

Glu12, His84ᵃ

Ile10, Val18, Ala31, Lys33, Val64, Phe80, Leu134

2

3

−6.664

Glu12, Asn132ᵃ, Glu162ᵃ

Val18, Ala144

3

ATP

−8.460

Tyr15, Asp86, Gln131, Asp145, Gly13ᵃ

Ile10, Val18, Ala31, Lys33, Lys129, Leu134

5

  1. ᵃ Carbon hydrogen bond.
  2. RMSD: 1.024 Å.